SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Dishman Pharmaceuticals and Chemicals Ltd Acquires Swiss Company For Over $75 Million

August 23, 2006 | 
1 min read
MUMBAI: Dishman Pharmaceuticals and Chemicals Ltd on Wednesday said it has acquired Swiss research based company Cabbogen Amcis AG from Solutia Europe (SESA) for over Rs 349.30 crore ($75 million).

>>> Discuss This Story

Mergers & acquisitions Asia
MORE ON THIS TOPIC
3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
 · 
3 min read
 · 
Gabrielle Masson
Big fish eats small, takeover of the company. Art collage.
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Chess made from China and EU, USA flags. Europe Union, USA and China relations
China
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
July 27, 2026
 · 
10 min read
 · 
Heather McKenzie
Psychedelic drug or psychedelics hallucinogenic drugs and hallucinogens representing states of consciousness and psychology or psychological hallucinating by taking mind altering substances in a 3D illustration style.
Psychedelics
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
July 24, 2026
 · 
3 min read
 · 
Gabrielle Masson